These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9757909)

  • 1. Immunoregulation by CD4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo: evidence for a reduction in the frequency of alloantigen-specific cytotoxic T cells in vitro.
    Roelen DL; Bushell AR; Niimi M; Young NT; Rust NA; Morris PJ; Wood KJ
    Hum Immunol; 1998 Sep; 59(9):529-39. PubMed ID: 9757909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
    Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
    Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.
    Pearson TC; Madsen JC; Larsen CP; Morris PJ; Wood KJ
    Transplantation; 1992 Sep; 54(3):475-83. PubMed ID: 1384183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
    Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
    J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of cognate help by CD4+ T cells and anergy of CD8+ T cells are the principal mechanisms for anti-leukocyte function-associated antigen-1/intercellular adhesion molecule-1-induced cardiac allograft tolerance.
    Bashuda H; Seino K; Ra C; Yagita H; Okumura K
    Transplantation; 1997 Jan; 63(1):113-8. PubMed ID: 9000671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
    Niimi M; Witzke O; Bushell A; Hara M; Morris PJ; Wood KJ
    Transplantation; 2000 Nov; 70(10):1524-8. PubMed ID: 11118100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
    Qin L; Ding Y; Tahara H; Bromberg JS
    J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of thymus to maintain operational tolerance to fully allogeneic cardiac grafts.
    Niimi M; Shirasugi N; Ikeda Y; Kan S; Takami H; Hamano K
    Ann Thorac Surg; 2001 Sep; 72(3):735-9. PubMed ID: 11565650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
    Arima T; Goss JA; Walp LA; Flye MW
    Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J; Zhang L; Tang J; Jiang S; Wang X
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2035. PubMed ID: 11120054
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential.
    Bushell A; Morris PJ; Wood KJ
    Transplantation; 1994 Jul; 58(2):133-9. PubMed ID: 8042231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
    J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.